WPW
ABBV icon

Warther Private Wealth’s AbbVie ABBV Stock Holding History

Warther Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,071
Closed -$377K – 85
2024
Q1 		$377K Sell
2,071
-2,965
-59% -$511K 0.17% 42
2023
Q4 		$780K Sell
5,036
-15,592
-76% -$2.27M 0.44% 28
2023
Q3 		$3.07M Buy
20,628
+2,225
+12% +$327K 2.04% 15
2023
Q2 		$2.48M Sell
18,403
-348
-2% -$51K 1.68% 17
2023
Q1 		$2.99M Buy
18,751
+1,083
+6% +$166K 2.28% 13
2022
Q4 		$2.86M Buy
17,668
+571
+3% +$87.6K 2.14% 14
2022
Q3 		$2.29M Buy
17,097
+5,191
+44% +$745K 1.82% 17
2022
Q2 		$1.83M Buy
11,906
+8,091
+212% +$1.24M 1.34% 20
2022
Q1 		$621K Buy
3,815
+626
+20% +$90.9K 0.4% 68
2021
Q4 		$432K Buy
3,189
+10
+0.3% +$1.18K 0.32% 77
2021
Q3 		$347K Sell
3,179
-62
-2% -$7.08K 0.31% 83
2021
Q2 		$370K Buy
+3,241
New +$365K 0.36% 72

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Warther Private Wealth's ABBV Position: Q2 2024 in Review

Warther Private Wealth sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 2,071 shares — an estimated $377K sold.

Warther Private Wealth first reported a position in ABBV in Q2 2021 and held it in 12 quarters. The position peaked at $3.07M in Q3 2023. 3,367 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Warther Private Wealth reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Warther Private Wealth sold 2,071 AbbVie shares in Q2 2024, an estimated $377K.
  • Warther Private Wealth first reported a position in AbbVie in Q2 2021 and held it in 12 quarters.
  • Warther Private Wealth's AbbVie position peaked at $3.07M in Q3 2023.
  • 3,367 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Warther Private Wealth's 13F filing for Q2 2024, filed 11 Jul 2024.